Publication:
Systems biology based drug repositioning for development of cancer therapy

dc.contributor.authorTURANLI, BESTE
dc.contributor.authorARĞA, KAZIM YALÇIN
dc.contributor.authorsTuranli, Beste; Altay, Ozlem; Boren, Jan; Turkez, Hasan; Nielsen, Jens; Uhlen, Mathias; Arga, Kazim Yalcin; Mardinoglu, Adil
dc.date.accessioned2022-03-10T15:25:48Z
dc.date.accessioned2026-01-11T19:06:27Z
dc.date.available2022-03-10T15:25:48Z
dc.date.issued2021
dc.description.abstractDrug repositioning is a powerful method that can assists the conventional drug discovery process by using existing drugs for treatment of a disease rather than its original indication. The first examples of repurposed drugs were discovered serendipitously, however data accumulated by high-throughput screenings and advancements in computational biology methods have paved the way for rational drug repositioning methods. As chemotherapeutic agents have notorious side effects that significantly reduce quality of life, drug repositioning promises repurposed noncancer drugs with little or tolerable adverse effects for cancer patients. Here, we review current drug-related data types and databases including some examples of web-based drug repositioning tools. Next, we describe systems biology approaches to be used in drug repositioning for effective cancer therapy. Finally, we highlight examples of mostly repurposed drugs for cancer treatment and provide an overview of future expectations in the field for development of effective treatment strategies.
dc.identifier.doi10.1016/j.semcancer.2019.09.020
dc.identifier.eissn1096-3650
dc.identifier.issn1044-579X
dc.identifier.pubmed31568815
dc.identifier.urihttps://hdl.handle.net/11424/220366
dc.identifier.wosWOS:000616365300006
dc.language.isoeng
dc.publisherACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
dc.relation.ispartofSEMINARS IN CANCER BIOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectSystems biology
dc.subjectCancer
dc.subjectDrug repositioning
dc.subjectSignature-based approaches
dc.subjectNetwork-based approaches
dc.titleSystems biology based drug repositioning for development of cancer therapy
dc.typereview
dspace.entity.typePublication
oaire.citation.endPage58
oaire.citation.startPage47
oaire.citation.titleSEMINARS IN CANCER BIOLOGY
oaire.citation.volume68

Files